The effect of recombinant human thrombopoietin (rhTPO) on sepsis patients with acute severe thrombocytopenia: a study protocol for a multicentre randomised controlled trial (RESCUE trial)

BACKGROUND: Sepsis is still a common critical disease with high morbidity and mortality in intensive care unit. Despite published guidelines for sepsis, development of antibiotic therapy and advanced organ support technologies, the mortality of sepsis patients is still 25% or more. It is necessary t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zhigang, Feng, Tienan, Xie, Yun, Huang, Peijie, Xie, Hui, Tian, Rui, Qian, Biyun, Wang, Ruilan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6729060/
https://www.ncbi.nlm.nih.gov/pubmed/31492102
http://dx.doi.org/10.1186/s12879-019-4388-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6729060/
https://www.ncbi.nlm.nih.gov/pubmed/31492102
http://dx.doi.org/10.1186/s12879-019-4388-2

Ejemplares similares